Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer.

MLA

Li, Qun, et al. “Synthesis and Structure-Activity Relationship of 3,4’-Bispyridinylethylenes: Discovery of a Potent 3-Isoquinolinylpyridine Inhibitor of Protein Kinase B (PKB/Akt) for the Treatment of Cancer.” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 7, Apr. 2006, pp. 2000–07. EBSCOhost, https://doi.org/10.1016/j.bmcl.2005.12.065.

APA

Li, Q., Woods, K. W., Thomas, S., Zhu, G.-D., Packard, G., Fisher, J., Li, T., Gong, J., Dinges, J., Song, X., Abrams, J., Luo, Y., Johnson, E. F., Shi, Y., Liu, X., Klinghofer, V., Des Jong, R., Oltersdorf, T., Stoll, V. S., … Giranda, V. L. (2006). Synthesis and structure-activity relationship of 3,4’-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters, 16(7), 2000–2007. https://doi.org/10.1016/j.bmcl.2005.12.065

Chicago

Li, Qun, Keith W Woods, Sheela Thomas, Gui-Dong Zhu, Garrick Packard, John Fisher, Tongmei Li, et al. 2006. “Synthesis and Structure-Activity Relationship of 3,4’-Bispyridinylethylenes: Discovery of a Potent 3-Isoquinolinylpyridine Inhibitor of Protein Kinase B (PKB/Akt) for the Treatment of Cancer.” Bioorganic & Medicinal Chemistry Letters 16 (7): 2000–2007. doi:10.1016/j.bmcl.2005.12.065.